Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

İsmail Bayrakci

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Annales D'Endocrinologie|June 23, 2019
Evaluation of upper gastrointestinal system in acromegalyPinar Sisman, Murat Pekgoz, Ismail Bayrakci, et al.
Oncology Research and Treatment|January 13, 2026
Proliferation-Guided Risk Stratification in HER2-Low vs. HER2-Positive Hormone Receptor-Positive Breast Cancer: A Multicenter Retrospective AnalysisSait Kitapli, Özgür Tanriverdi, İsmail Bayrakci, et al.
Journal of Clinical Medicine|February 27, 2026
Outcomes of First-Line PARP Inhibitor Therapy in Ovarian Cancer: A Multicenter Retrospective AnalysisBaris Koksal, Hasan Cagri Yildirim, Deniz Can Guven, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Annales D'Endocrinologie|June 23, 2019
Evaluation of upper gastrointestinal system in acromegalyPinar Sisman, Murat Pekgoz, Ismail Bayrakci, et al.
Oncology Research and Treatment|January 13, 2026
Proliferation-Guided Risk Stratification in HER2-Low vs. HER2-Positive Hormone Receptor-Positive Breast Cancer: A Multicenter Retrospective AnalysisSait Kitapli, Özgür Tanriverdi, İsmail Bayrakci, et al.
Journal of Clinical Medicine|February 27, 2026
Outcomes of First-Line PARP Inhibitor Therapy in Ovarian Cancer: A Multicenter Retrospective AnalysisBaris Koksal, Hasan Cagri Yildirim, Deniz Can Guven, et al.
Pageof 1